[1]
“The safety of alpha fetoprotein in diagnosis of hepatocellular carcinoma in patients with type 2 diabetes mellitus ”, Ann Med Res , vol. 26, no. 12, pp. 2961–2965, May 2021, Accessed: Oct. 22, 2025. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/1883